)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Create Medic
Create Medic (5187) investor relations material
Create Medic Q3 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2026 earnings summary2 Nov, 2026
Executive summary
9M 2026 net sales rose 4.1% YoY to ¥10,467 million; operating profit fell 44.2% to ¥509 million and profit attributable to owners of parent declined 54.7% to ¥301 million.
Comprehensive income increased 82.8% YoY to ¥699 million from ¥382 million.
Financial highlights
Cost of sales rose 12.8% to ¥6,172 million; gross profit fell 6.3% to ¥4,295 million and SG&A increased 3.2% to ¥3,785 million.
Ordinary profit declined 34.8% to ¥568 million from ¥871 million.
Basic EPS was ¥37.05, down from ¥78.45; diluted EPS was ¥33.30, down from ¥76.57.
Outlook and guidance
FY2026 forecast: net sales ¥13,960 million (+2.5%), operating profit ¥760 million (-24.4%), ordinary profit ¥800 million (-19.0%) and parent-attributable profit ¥560 million (-21.5%).
FY2026 forecast basic EPS is ¥68.90; no earnings forecast revisions were announced.
Own-brand plans include expanding H1 launches; European exports are expected to remain firm as MDR transitions progress. India sales operations are starting through a local subsidiary, and OEM sales are expected to grow.
Medium-term operating-profit targets: ¥1.3 billion and 8% margin in FY2027; ¥3 billion and 15% margin in FY2034.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Create Medic
- Sales up, profits down; full-year forecast revised with higher dividend and lower earnings.5187
Q2 2026 - Net sales grew 3.8% but profit attributable to owners plunged 98% year-over-year.5187Q3 2024
- Net sales rose 4.6% and profit attributable to owners of parent jumped 73.9% year-over-year.5187Q2 2024
- Net sales rose 3.5% and net profit surged 446.0% year-over-year, with higher dividends declared.5187Q4 2024
- Q1 2025 delivered robust profit growth, but full-year net profit is forecast to decline slightly.5187Q1 2025
- Strong first-half profit growth and higher sales, with robust full-year outlook.5187Q2 2025
- Sales and operating profit rose, but net income fell; full-year growth and higher dividend expected.5187Q3 2025
- Sales and operating profit rose, but net profit fell; moderate growth forecast for FY2026.5187Q4 2025
- Q1 2026 delivered higher sales but lower profits, with 2026 guidance signaling profit recovery.5187Q1 2026
Next Create Medic earnings date
Q4 202612 Feb, 2027
Create Medic
Next Create Medic earnings date
Q4 202612 Feb, 2027
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)